ID   PAN2_HUMAN              Reviewed;        1202 AA.
AC   Q504Q3; O75189; Q76E12; Q8IVE1;
DT   20-MAR-2007, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   15-MAR-2017, entry version 126.
DE   RecName: Full=PAB-dependent poly(A)-specific ribonuclease subunit PAN2 {ECO:0000255|HAMAP-Rule:MF_03182};
DE            Short=hPan2;
DE            EC=3.1.13.4 {ECO:0000255|HAMAP-Rule:MF_03182};
DE   AltName: Full=Inactive ubiquitin carboxyl-terminal hydrolase 52 {ECO:0000255|HAMAP-Rule:MF_03182};
DE   AltName: Full=PAB1P-dependent poly(A)-nuclease {ECO:0000255|HAMAP-Rule:MF_03182};
DE   AltName: Full=PAN deadenylation complex catalytic subunit 2 {ECO:0000255|HAMAP-Rule:MF_03182};
GN   Name=PAN2 {ECO:0000255|HAMAP-Rule:MF_03182}; Synonyms=KIAA0710, USP52;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, CATALYTIC ACTIVITY,
RP   SUBCELLULAR LOCATION, INTERACTION WITH PAN3 AND POLYADENYLATE-BINDING
RP   PROTEIN, MUTAGENESIS OF ASP-1087, AND VARIANT LEU-179.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=14583602; DOI=10.1074/jbc.M309125200;
RA   Uchida N., Hoshino S., Katada T.;
RT   "Identification of a human cytoplasmic poly(A) nuclease complex
RT   stimulated by poly(A)-binding protein.";
RL   J. Biol. Chem. 279:1383-1391(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT
RP   LEU-179.
RC   TISSUE=Brain;
RX   PubMed=9734811; DOI=10.1093/dnares/5.3.169;
RA   Ishikawa K., Nagase T., Suyama M., Miyajima N., Tanaka A., Kotani H.,
RA   Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. X.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 5:169-176(1998).
RN   [3]
RP   SEQUENCE REVISION.
RA   Ohara O., Suyama M., Nagase T., Ishikawa K.;
RL   Submitted (JAN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND
RP   VARIANTS ASN-32 AND LEU-179.
RC   TISSUE=Eye, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   LACK OF UBIQUITIN CARBOXYL TERMINAL HYDROLASE ACTIVITY.
RX   PubMed=14715245; DOI=10.1016/j.bbrc.2003.12.050;
RA   Quesada V., Diaz-Perales A., Gutierrez-Fernandez A., Garabaya C.,
RA   Cal S., Lopez-Otin C.;
RT   "Cloning and enzymatic analysis of 22 novel human ubiquitin-specific
RT   proteases.";
RL   Biochem. Biophys. Res. Commun. 314:54-62(2004).
RN   [6]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=16284618; DOI=10.1038/nsmb1016;
RA   Yamashita A., Chang T.-C., Yamashita Y., Zhu W., Zhong Z.,
RA   Chen C.-Y.A., Shyu A.-B.;
RT   "Concerted action of poly(A) nucleases and decapping enzyme in
RT   mammalian mRNA turnover.";
RL   Nat. Struct. Mol. Biol. 12:1054-1063(2005).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1189, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=18625844; DOI=10.1083/jcb.200801196;
RA   Zheng D., Ezzeddine N., Chen C.Y., Zhu W., He X., Shyu A.B.;
RT   "Deadenylation is prerequisite for P-body formation and mRNA decay in
RT   mammalian cells.";
RL   J. Cell Biol. 182:89-101(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-791, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1189, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   INTERACTION WITH PAN3.
RX   PubMed=23932717; DOI=10.1016/j.molcel.2013.07.011;
RA   Christie M., Boland A., Huntzinger E., Weichenrieder O.,
RA   Izaurralde E.;
RT   "Structure of the PAN3 pseudokinase reveals the basis for interactions
RT   with the PAN2 deadenylase and the GW182 proteins.";
RL   Mol. Cell 51:360-373(2013).
RN   [14]
RP   VARIANT [LARGE SCALE ANALYSIS] VAL-1201.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Catalytic subunit of the poly(A)-nuclease (PAN)
CC       deadenylation complex, one of two cytoplasmic mRNA deadenylases
CC       involved in general and miRNA-mediated mRNA turnover. PAN
CC       specifically shortens poly(A) tails of RNA when the poly(A)
CC       stretch is bound by poly(A)-binding protein (PABP), which is
CC       followed by rapid degradation of the shortened mRNA tails by the
CC       CCR4-NOT complex. Deadenylated mRNAs are then degraded by two
CC       alternative mechanisms, namely exosome-mediated 3'-5'
CC       exonucleolytic degradation, or deadenlyation-dependent mRNA
CC       decaping and subsequent 5'-3' exonucleolytic degradation by XRN1.
CC       {ECO:0000255|HAMAP-Rule:MF_03182, ECO:0000269|PubMed:14583602,
CC       ECO:0000269|PubMed:16284618}.
CC   -!- CATALYTIC ACTIVITY: Exonucleolytic cleavage of poly(A) to 5'-AMP.
CC       {ECO:0000255|HAMAP-Rule:MF_03182, ECO:0000269|PubMed:14583602}.
CC   -!- ENZYME REGULATION: Positively regulated by the regulatory subunit
CC       PAN3. {ECO:0000255|HAMAP-Rule:MF_03182}.
CC   -!- SUBUNIT: Interacts with the regulatory subunit PAN3 to form the
CC       poly(A)-nuclease (PAN) deadenylation complex (PubMed:14583602,
CC       PubMed:23932717). Interacts with ZFP36 (By similarity).
CC       {ECO:0000255|HAMAP-Rule:MF_03182, ECO:0000269|PubMed:14583602,
CC       ECO:0000269|PubMed:23932717}.
CC   -!- INTERACTION:
CC       Q58A45:PAN3; NbExp=6; IntAct=EBI-1058976, EBI-2513054;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:14583602,
CC       ECO:0000269|PubMed:16284618}. Cytoplasm, P-body
CC       {ECO:0000255|HAMAP-Rule:MF_03182, ECO:0000269|PubMed:18625844}.
CC       Nucleus {ECO:0000255|HAMAP-Rule:MF_03182,
CC       ECO:0000269|PubMed:16284618}. Note=Shuttles between nucleus and
CC       cytoplasm. {ECO:0000255|HAMAP-Rule:MF_03182,
CC       ECO:0000269|PubMed:16284618}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q504Q3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q504Q3-2; Sequence=VSP_023749;
CC       Name=3;
CC         IsoId=Q504Q3-3; Sequence=VSP_023748;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the peptidase C19 family. PAN2 subfamily.
CC       {ECO:0000255|HAMAP-Rule:MF_03182}.
CC   -!- CAUTION: Has no ubiquitin carboxyl terminal hydrolase activity
CC       since it lacks a conserved catalytic Cys at position 525.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA31685.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB107585; BAD02263.1; -; mRNA.
DR   EMBL; AB014610; BAA31685.2; ALT_INIT; mRNA.
DR   EMBL; BC024043; AAH24043.1; -; mRNA.
DR   EMBL; BC094885; AAH94885.1; -; mRNA.
DR   CCDS; CCDS44922.1; -. [Q504Q3-1]
DR   CCDS; CCDS53802.1; -. [Q504Q3-3]
DR   CCDS; CCDS8915.1; -. [Q504Q3-2]
DR   RefSeq; NP_001120932.1; NM_001127460.2.
DR   RefSeq; NP_001159751.1; NM_001166279.1.
DR   RefSeq; NP_055686.3; NM_014871.4.
DR   UniGene; Hs.273397; -.
DR   ProteinModelPortal; Q504Q3; -.
DR   BioGrid; 115252; 345.
DR   DIP; DIP-50708N; -.
DR   IntAct; Q504Q3; 16.
DR   STRING; 9606.ENSP00000401721; -.
DR   MEROPS; C19.978; -.
DR   iPTMnet; Q504Q3; -.
DR   PhosphoSitePlus; Q504Q3; -.
DR   BioMuta; PAN2; -.
DR   DMDM; 296439280; -.
DR   EPD; Q504Q3; -.
DR   MaxQB; Q504Q3; -.
DR   PaxDb; Q504Q3; -.
DR   PeptideAtlas; Q504Q3; -.
DR   PRIDE; Q504Q3; -.
DR   Ensembl; ENST00000257931; ENSP00000257931; ENSG00000135473. [Q504Q3-3]
DR   Ensembl; ENST00000425394; ENSP00000401721; ENSG00000135473. [Q504Q3-1]
DR   Ensembl; ENST00000440411; ENSP00000388231; ENSG00000135473. [Q504Q3-2]
DR   Ensembl; ENST00000548043; ENSP00000449861; ENSG00000135473. [Q504Q3-1]
DR   Ensembl; ENST00000610546; ENSP00000481859; ENSG00000135473. [Q504Q3-1]
DR   GeneID; 9924; -.
DR   KEGG; hsa:9924; -.
DR   UCSC; uc001skx.3; human. [Q504Q3-1]
DR   CTD; 9924; -.
DR   DisGeNET; 9924; -.
DR   GeneCards; PAN2; -.
DR   HGNC; HGNC:20074; PAN2.
DR   neXtProt; NX_Q504Q3; -.
DR   OpenTargets; ENSG00000135473; -.
DR   PharmGKB; PA162398664; -.
DR   eggNOG; KOG1275; Eukaryota.
DR   eggNOG; COG0847; LUCA.
DR   GeneTree; ENSGT00390000013978; -.
DR   HOGENOM; HOG000230585; -.
DR   HOVERGEN; HBG089847; -.
DR   InParanoid; Q504Q3; -.
DR   KO; K12571; -.
DR   OMA; ILHQMHY; -.
DR   OrthoDB; EOG091G01KS; -.
DR   PhylomeDB; Q504Q3; -.
DR   TreeFam; TF105657; -.
DR   BRENDA; 3.1.13.4; 2681.
DR   Reactome; R-HSA-429947; Deadenylation of mRNA.
DR   GeneWiki; USP52; -.
DR   GenomeRNAi; 9924; -.
DR   PRO; PR:Q504Q3; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000135473; -.
DR   CleanEx; HS_PAN2; -.
DR   ExpressionAtlas; Q504Q3; baseline and differential.
DR   Genevisible; Q504Q3; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0000932; C:P-body; IBA:GO_Central.
DR   GO; GO:0031251; C:PAN complex; IDA:UniProtKB.
DR   GO; GO:0000175; F:3'-5'-exoribonuclease activity; IDA:UniProtKB.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   GO; GO:0004535; F:poly(A)-specific ribonuclease activity; IDA:UniProtKB.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0000289; P:nuclear-transcribed mRNA poly(A) tail shortening; IBA:GO_Central.
DR   Gene3D; 2.130.10.10; -; 1.
DR   Gene3D; 3.30.420.10; -; 1.
DR   HAMAP; MF_03182; PAN2; 1.
DR   InterPro; IPR013520; Exonuclease_RNaseT/DNA_pol3.
DR   InterPro; IPR030843; PAN2.
DR   InterPro; IPR028881; PAN2_dom.
DR   InterPro; IPR012337; RNaseH-like_dom.
DR   InterPro; IPR028889; USP_dom.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   Pfam; PF00929; RNase_T; 1.
DR   Pfam; PF13423; UCH_1; 1.
DR   SMART; SM00479; EXOIII; 1.
DR   SUPFAM; SSF50978; SSF50978; 1.
DR   SUPFAM; SSF53098; SSF53098; 1.
DR   PROSITE; PS50235; USP_3; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Cytoplasm; Exonuclease;
KW   Hydrolase; mRNA processing; Nuclease; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat; WD repeat.
FT   CHAIN         1   1202       PAB-dependent poly(A)-specific
FT                                ribonuclease subunit PAN2.
FT                                /FTId=PRO_0000280521.
FT   REPEAT       64    107       WD 1.
FT   REPEAT      108    164       WD 2.
FT   REPEAT      165    226       WD 3.
FT   REPEAT      227    276       WD 4.
FT   REPEAT      277    318       WD 5.
FT   REPEAT      319    358       WD 6.
FT   DOMAIN      517    924       USP. {ECO:0000255|HAMAP-Rule:MF_03182}.
FT   DOMAIN      975   1147       Exonuclease. {ECO:0000255|HAMAP-
FT                                Rule:MF_03182}.
FT   MOD_RES     791    791       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1189   1189       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     643    643       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:9734811}.
FT                                /FTId=VSP_023748.
FT   VAR_SEQ     689    692       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14583602,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_023749.
FT   VARIANT      32     32       S -> N (in dbSNP:rs11558139).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_031162.
FT   VARIANT     179    179       I -> L (in dbSNP:rs1918496).
FT                                {ECO:0000269|PubMed:14583602,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9734811}.
FT                                /FTId=VAR_031163.
FT   VARIANT    1201   1201       A -> V (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036359.
FT   MUTAGEN    1087   1087       D->A: Loss of exonuclease activity.
FT                                {ECO:0000269|PubMed:14583602}.
FT   CONFLICT      9      9       G -> E (in Ref. 4; AAH94885).
FT                                {ECO:0000305}.
FT   CONFLICT   1091   1091       I -> V (in Ref. 4; AAH94885).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1202 AA;  135368 MW;  579194C102FCA019 CRC64;
     MNFEGLDPGL AEYAPAMHSA LDPVLDAHLN PSLLQNVELD PEGVALEALP VQESVHIMEG
     VYSELHSVVA EVGVPVSVSH FDLHEEMLWV GSHGGHATSF FGPALERYSS FQVNGSDDIR
     QIQSLENGIL FLTKNNLKYM ARGGLIIFDY LLDENEDMHS LLLTDSSTLL VGGLQNHIIE
     IDLNTVQETQ KYAVETPGVT IMRQTNRFFF CGHTSGKVSL RDLRTFKVEH EFDAFSGSLS
     DFDVHGNLLA ACGFSSRLTG LACDRFLKVY DLRMMRAITP LQVHVDPAFL RFIPTYTSRL
     AIISQSGQCQ FCEPTGLANP ADIFHVNPVG PLLMTFDVSA SKQALAFGDS EGCVHLWTDS
     PEPSFNPYSR ETEFALPCLV DSLPPLDWSQ DLLPLSLIPV PLTTDTLLSD WPAANSAPAP
     RRAPPVDAEI LRTMKKVGFI GYAPNPRTRL RNQIPYRLKE SDSEFDSFSQ VTESPVGREE
     EPHLHMVSKK YRKVTIKYSK LGLEDFDFKH YNKTLFAGLE PHIPNAYCNC MIQVLYFLEP
     VRCLIQNHLC QKEFCLACEL GFLFHMLDLS RGDPCQGNNF LRAFRTIPEA SALGLILADS
     DEASGKGNLA RLIQRWNRFI LTQLHQDMQE LEIPQAYRGA GGSSFCSSGD SVIGQLFSCE
     MENCSLCRCG SETVRASSTL LFTLSYPDGS KSDKTGKNYD FAQVLKRSIC LDQNTQAWCD
     TCEKYQPTIQ TRNIRHLPDI LVINCEVNSS KEADFWRMQA EVAFKMAVKK HGGEISKNKE
     FALADWKELG SPEGVLVCPS IEELKNVWLP FSIRMKMTKN KGLDVCNWTD GDEMQWGPAR
     AEEEHGVYVY DLMATVVHIL DSRTGGSLVA HIKVGETYHQ RKEGVTHQQW YLFNDFLIEP
     IDKHEAVQFD MNWKVPAILY YVKRNLNSRY NLNIKNPIEA SVLLAEASLA RKQRKTHTTF
     IPLMLNEMPQ IGDLVGLDAE FVTLNEEEAE LRSDGTKSTI KPSQMSVARI TCVRGQGPNE
     GIPFIDDYIS TQEQVVDYLT QYSGIKPGDL DAKISSKHLT TLKSTYLKLR FLIDIGVKFV
     GHGLQKDFRV INLMVPKDQV LDTVYLFHMP RKRMISLRFL AWYFLDLKIQ GETHDSIEDA
     RTALQLYRKY LELSKNGTEP ESFHKVLKGL YEKGRKMDWK VPEPEGQTSP KNAAVFSSVL
     AL
//
